Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $2.30 on 13-10-2026 at 09:55:58
Change $0.00 0%
Buy $2.32
Sell $2.30
Last Trade: Sell 130.00 at $2.30
Day's Volume: 48,232
Last Close: $2.30
Open: $2.29
ISIN: GG00BKTRRM22
Day's Range $2.28 - $2.32
52wk Range: $1.585 - $2.64
Market Capitalisation: $738.62m
VWAP: $2.305026
Shares in Issue: 321.14m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 130 $2.30 Automatic Execution
10:55:58 - 13-Oct-26
Sell* 227 $2.30 Automatic Execution
10:55:58 - 13-Oct-26
Sell* 210 $2.30 Automatic Execution
10:55:58 - 13-Oct-26
Sell* 313 $2.31 Automatic Execution
10:55:58 - 13-Oct-26
Buy* 7,143 $2.32 Automatic Execution
10:55:58 - 13-Oct-26
Buy* 371 $2.32 Automatic Execution
10:55:58 - 13-Oct-26
Buy* 1,250 $2.30697 Ordinary
10:52:57 - 13-Oct-26
Buy* 68 $2.30697 Ordinary
10:22:30 - 13-Oct-26
Unknown* 426 $2.304328 Ordinary
Currency Conversion
09:47:55 - 13-Oct-26
Buy* 8,000 $2.307 Ordinary
09:23:18 - 13-Oct-26
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
12th Oct 2026 (Mon) 2.22 2.30 2.22 2.30 853,201
9th Oct 2026 (Fri) 2.24 2.25 2.19 2.22 569,226
8th Oct 2026 (Thu) 2.27 2.28 2.19 2.24 241,300
7th Oct 2026 (Wed) 2.33 2.33 2.27 2.30 1,102,434
6th Oct 2026 (Tue) 2.32 2.34 2.31 2.33 725,529
5th Oct 2026 (Mon) 2.33 2.34 2.31 2.32 1,653,390
2nd Oct 2026 (Fri) 2.34 2.36 2.33 2.35 313,593
1st Oct 2026 (Thu) 2.38 2.38 2.32 2.34 118,096
30th Sep 2026 (Wed) 2.40 2.40 2.33 2.38 289,694
29th Sep 2026 (Tue) 2.32 2.34 2.32 2.33 318,315
28th Sep 2026 (Mon) 2.35 2.35 2.30 2.34 92,038
25th Sep 2026 (Fri) 2.38 2.38 2.33 2.36 255,232
24th Sep 2026 (Thu) 2.36 2.39 2.34 2.34 174,355
23rd Sep 2026 (Wed) 2.39 2.41 2.35 2.35 72,194
22nd Sep 2026 (Tue) 2.38 2.41 2.38 2.39 120,362
21st Sep 2026 (Mon) 2.34 2.39 2.34 2.38 184,001
18th Sep 2026 (Fri) 2.38 2.38 2.33 2.34 669,802
17th Sep 2026 (Thu) 2.39 2.40 2.37 2.39 224,072
16th Sep 2026 (Wed) 2.36 2.40 2.33 2.36 231,686
15th Sep 2026 (Tue) 2.31 2.38 2.30 2.36 418,081
14th Sep 2026 (Mon) 2.34 2.38 2.32 2.32 195,147
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
9th Oct 2026 10:00 am RNS Holding(s) in Company
1st Oct 2026 7:00 am RNS Total Voting Rights
21st Sep 2026 7:00 am RNS Transaction in Own Shares
16th Sep 2026 7:00 am RNS Transaction in Own Shares
15th Sep 2026 7:00 am RNS Transaction in Own Shares
14th Sep 2026 7:02 am RNS Transaction in Own Shares
14th Sep 2026 7:01 am RNS Monthly Valuation Update and Factsheet
14th Sep 2026 7:00 am RNS Half-year Financial Report
11th Sep 2026 7:01 am RNS Transaction in Own Shares
11th Sep 2026 7:00 am RNS Additional investment in Encoded Therapeutics
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

RTW Biotech NAV rises 15% as public investments drive returns

14th Sep 2026 11:49

(Alliance News) - RTW Biotech Opportunities Ltd on Monday reported a positive net asset value return for the first half of 2026, supported by improving biotechnology sector sentiment, M&A activity and clinical progress across its portfolio. Read More

RTW Biotech notes further investment in investee Encoded Therapeutics

11th Sep 2026 10:46

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said there was an additional investment in the financing of private portfolio company Encoded Therapeutics. Read More

UK earnings, trading statements calendar - next 7 days

7th Sep 2026 11:27

Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2026 14:24

Read More

IN BRIEF: RTW Biotech Opportunities get 0.2% uplift from Alesta deal

19th Aug 2026 12:40

RTW Biotech Opportunities Ltd - investor in life sciences sector - Notes the announcement by BioMarin Pharmaceuticals Inc that it has agreed to buy RTW Biotech portfolio holding Alesta Therapeutics, which will give net asset value a boost. BioMarin will pay USD275 million upfront in cash for Alesta's lead asset, ALE1, which RTW says represents a 41% uplift on its own carrying value for Alesta. This will result in a USD1.6 million, or 0.2%, addition to RTW Biotech's net asset value as of July 31. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value10,734.32
Change78.04

Login to your account

Forgot Password?

Not Registered